Péter Nagy

2.7k total citations
76 papers, 1.8k citations indexed

About

Péter Nagy is a scholar working on Gastroenterology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Péter Nagy has authored 76 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Gastroenterology, 26 papers in Surgery and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Péter Nagy's work include Gastroesophageal reflux and treatments (23 papers), Helicobacter pylori-related gastroenterology studies (18 papers) and Reproductive Biology and Fertility (14 papers). Péter Nagy is often cited by papers focused on Gastroesophageal reflux and treatments (23 papers), Helicobacter pylori-related gastroenterology studies (18 papers) and Reproductive Biology and Fertility (14 papers). Péter Nagy collaborates with scholars based in Sweden, United States and Spain. Péter Nagy's co-authors include Paul Devroey, Saga Johansson, Herman Tournaye, A.C. Van Steirteghem, Michael Molloy‐Bland, Greta Verheyen, F. Ubaldi, Alain Goossens, S. Silber and Lars Lundell and has published in prestigious journals such as Gastroenterology, PLoS ONE and Neurology.

In The Last Decade

Péter Nagy

67 papers receiving 1.7k citations

Peers

Péter Nagy
Eli Geva Israel
E. Conti Italy
Marian D. Damewood United States
Craig A. Winkel United States
Yoon-Ok Ahn South Korea
Ahmet Erdem Türkiye
Eli Geva Israel
Péter Nagy
Citations per year, relative to Péter Nagy Péter Nagy (= 1×) peers Eli Geva

Countries citing papers authored by Péter Nagy

Since Specialization
Citations

This map shows the geographic impact of Péter Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Nagy more than expected).

Fields of papers citing papers by Péter Nagy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Nagy. The network helps show where Péter Nagy may publish in the future.

Co-authorship network of co-authors of Péter Nagy

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Nagy. A scholar is included among the top collaborators of Péter Nagy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Nagy. Péter Nagy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vermeire, Séverine, Silvio Danese, William J. Sandborn, et al.. (2023). Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn’s Disease. Journal of Crohn s and Colitis. 18(5). 708–719. 8 indexed citations
2.
Peura, David A., et al.. (2016). A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction. Postgraduate Medicine. 128(6). 577–583. 5 indexed citations
3.
Sáez, María Eugenia, Antonio González‐Pérez, David Gaist, et al.. (2016). Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study. Epilepsy & Behavior. 62. 72–80. 9 indexed citations
4.
Nagy, Péter, Saga Johansson, & Michael Molloy‐Bland. (2016). Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathogens. 8(1). 8–8. 152 indexed citations
5.
Andersson, Tommy, et al.. (2014). Effect of Esomeprazole With/Without Acetylsalicylic Acid, Omeprazole and Lansoprazole on Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers. American Journal of Cardiovascular Drugs. 14(3). 217–227. 11 indexed citations
6.
Sáez, María Eugenia, Antonio González‐Pérez, Saga Johansson, Péter Nagy, & Luis A. Garcı́a Rodrı́guez. (2014). Patterns in the Use of Low-Dose Acetylsalicylic Acid and Other Therapies Following Upper Gastrointestinal Bleeding. American Journal of Cardiovascular Drugs. 14(6). 443–450. 6 indexed citations
7.
González‐Pérez, Antonio, María Eugenia Sáez, Saga Johansson, Péter Nagy, & Luis A. Garcı́a Rodrı́guez. (2014). Risk Factors Associated with Uncomplicated Peptic Ulcer and Changes in Medication Use after Diagnosis. PLoS ONE. 9(7). e101768–e101768. 16 indexed citations
8.
Ruigómez, Ana, Saga Johansson, Péter Nagy, Mar Martín‐Pérez, & Luis A. Garcı́a Rodrı́guez. (2014). Risk of uncomplicated peptic ulcer disease in a cohort of new users of low-dose acetylsalicylic acid for secondary prevention of cardiovascular events. BMC Gastroenterology. 14(1). 205–205. 11 indexed citations
9.
Martín‐Merino, Elisa, Saga Johansson, Péter Nagy, & Luis A. Garcı́a Rodrı́guez. (2013). Effect of Baseline Gastrointestinal Risk and Use of Proton Pump Inhibitors on Frequency of Discontinuation of Aspirin for Secondary Cardiovascular Prevention in United Kingdom Primary Care. The American Journal of Cardiology. 112(8). 1075–1082. 14 indexed citations
10.
Johansson, Saga, Péter Nagy, Lucía Cea Soriano, & Luis A. Garcı́a Rodrı́guez. (2013). Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care. Thrombosis and Haemostasis. 111(1). 131–139. 7 indexed citations
11.
Wilder‐Smith, Clive H., et al.. (2010). The effects of dose and timing of esomeprazole administration on 24‐h, daytime and night‐time acid inhibition in healthy volunteers. Alimentary Pharmacology & Therapeutics. 32(10). 1249–1256. 27 indexed citations
12.
Katz, Philip O., David A. Johnson, Deborah Levine, et al.. (2010). A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing?. Alimentary Pharmacology & Therapeutics. 32(3). 443–447. 8 indexed citations
13.
Tulassay, Zsolt, Manfred Stolte, Maria Sjölund, et al.. (2008). Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. European Journal of Gastroenterology & Hepatology. 20(6). 526–536. 26 indexed citations
14.
Dozortsev, Dmitri, Péter Nagy, S. Abdelmassih, et al.. (2004). The optimal time for intracytoplasmic sperm injection in the human is from 37 to 41 hours after administration of human chorionic gonadotropin. Fertility and Sterility. 82(6). 1492–1496. 45 indexed citations
15.
Jakó, János, et al.. (2003). Familial Malignant Blood Diseases: Lessons Learned from a 20-year Period. Leukemia & lymphoma. 45(1). 109–111. 4 indexed citations
16.
Juhász, Judit, Péter Nagy, Margit Kulcsár, & Gy. Huszenicza. (2000). Methods for Semen and Endocrinological Evaluation of The Stallion: A Review. Acta Veterinaria Brno. 69(4). 247–259. 10 indexed citations
17.
Dozortsev, Dmitri, Allen Coleman, Péter Nagy, et al.. (2000). Nucleoli in a pronuclei-stage mouse embryo are represented by major satellite DNA of interconnecting chromosomes. Fertility and Sterility. 73(2). 366–371. 20 indexed citations
18.
Arilla, E., et al.. (1999). Renal transplant waiting list exclusion causes: hepatitis C virus infection and liver disease prevalence. Transplantation Proceedings. 31(7). 3038–3040. 1 indexed citations
19.
Tournaye, Herman, M. Camus, A. Goossens, et al.. (1995). Recent concepts in the management of infertility because of non-obstructive azoospermia. Human Reproduction. 10(suppl 1). 115–119. 128 indexed citations
20.
Major, Tibor, et al.. (1965). [INVESTIGATIONS ON CHRONIC BRONCHITIS AS A DISEASE OF THE MASSES].. PubMed. 106. 103–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026